drugset

drugset / Trial / NCT00283036

APROVE : Irbesartan in Hypertension

NCT00283036 ↗

Phase 4 Completed 200 enrolled Sanofi Bristol-Myers Squibb · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

Study objective : To compare efficacy and tolerability of posology adaptation of Irbesartan in ambulatory Hypertensive patients

Timeline

Start: 2005-04
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Irbesartan	Small molecule	—	—

Indications